{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-205527","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2023-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.245371+00:00","generated_at":"2026-06-12T00:42:58.487936+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Elevance Health names Mark Kaye new CFO to succeed retiring John Gallina; reaffirms 2023 guidance","bullets":["Mark Kaye appointed EVP and CFO effective Nov 1, 2023; will serve as CFO Designate starting Sep 6.","John Gallina retiring after ~30 years at company; will remain as Special Advisor to CEO post-transition.","Kaye's compensation: base salary $900k, target bonus 120% of base, LTI target $5.5M; one-time awards: $8M RSUs, $3.7M equity mix, and $2.5M cash.","Kaye previously CFO at Moody's (2018-2023), held senior finance roles at MassMutual and Voya.","Company reaffirms FY 2023 adjusted net income guidance > $32.85 per share; net income > $29.09 per share."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-205527","json":"https://secwatch.observer/filing/0001193125-23-205527.json","markdown":"https://secwatch.observer/filing/0001193125-23-205527.md","text":"https://secwatch.observer/filing/0001193125-23-205527.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000119312523205527/0001193125-23-205527-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000119312523205527/d492032d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T00:42:58.487936+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3839414154","claim":"Mark Kaye was appointed as Executive Vice President and Chief Financial Officer at Elevance Health, Inc..","evidence_excerpt":"On August 8, 2023, Elevance Health, Inc. (the “Company”) announced that Mark Kaye has been named Executive Vice President and Chief Financial Officer (“CFO”) of the Company, effective November 1, 2023 (the “Transition Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1156039/000119312523205527/0001193125-23-205527-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"f92518a98e","claim":"John Gallina retired as Chief Financial Officer at Elevance Health, Inc..","evidence_excerpt":"Mr. Kaye succeeds John Gallina, who, after nearly thirty years of dedicated services to the Company, has decided to retire as CFO.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1156039/000119312523205527/0001193125-23-205527-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}